Glucomannan in prevention of oxidative stress and inflammation occurring in adjuvant arthritis

Neuroendocrinology Letters

Volumn 29, Issue 5, 2008, Pages 691-696

  Bauerová, Katarína ^a   Poništ, Silvester ^a   Navarová, Jana ^a   Dubničková, Martina ^b   Paulovičová, Ema ^c   Pajtinka, Martin ^c   Kogan, Grigorij ^c,d   Mihalová, Danica ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Department of Pharmaceutical Analysis and Nuclear Pharmacy   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d EUROPEAN COMMISSION   (Belgium)

Author keywords

Adjuvant arthritis; Carbonyls; Cyclosporin A; Gamma glutamyltransferase; Glucomannan; Immunomodulators; Inflammation; Lipid peroxidation; Macrophages; N acetylbeta D glucosaminidase; Oxidative stress; Protein; Rheumatoid arthritis; Total antioxidant status

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CARBONYL DERIVATIVE; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; LYSOZYME; MANNAN; N ACETYL BETA GLUCOSAMINIDASE; PEROXIDASE;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ACTIVITY; IMMUNIZATION; IN VIVO STUDY; LEWIS RAT; MACROPHAGE FUNCTION; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; TISSUE HOMOGENATE;

EID: 57149135204     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bauerová K, Bezek Š (1999). Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen. Physiol. Biophys. 18: 15-20.
2. Barrett AJ, Heath MF (1977). Lysosomal enzymes. In: Dingle JT, editor. Lysosomes: A Laboratory Handbook, 2nd ed, Amsterdam: Elsevier. p. 19-147.
3. Brown RK, Kelly FJ (1996). Peroxides and other products. In: Punchard NA, Kelly FJ, editors. Free Radicals, a Practical Approach. Oxford University Press. Oxford. p. 119-131.
4. Bukovský M, Mlynarčík D, Koščtová H (1998). Change of immunomodulating properties of Escherichia coli caused by artificial resistance to amine oxides. Farm.Obzor 57: 59-68 (In Slovak).
5. Chauchan N, Dongmei L, Singh P, Calderone R, Kruppa M (2002). The cell-wall of Candida spp. In Candida and candidiasis. Editors Calderone RA, ASM Press. Washington DC. p. 159-171.
6. Chorvatovičová D, Machovǎ E, Šandula J, Kogan G (1999). Protective effect of the yeast glucomannan against cyclophosphamide -induced mutagenicity. Mutat. Res. 444: 117-122.
7. Cross A, Barnes T, Bucknall RC, Edwards SW, Moots RJ (2006). Neutrophil apoptosis in rheumatoid arthritis is regulated by local oxygen tensions within joints. J. Leukoc. Biol. 80: 521-528.
8. Dijkgraaf GPJ, Huijuan L, Bussey H (2002). Cell-wall β-D-glucans of Saccharomyces cerevisiae. In Biopolymers. Polysaccharides II. de Baets S, Vandamme EJ, Steinbuchel A, Wiley VCH Editors.Verlag GmbH. Weinheim. p. 179-214.
9. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006). Biomarkers of oxidative damage in human disease. Clin. Chem. 52:601-623.
10. Dhalla NS, Temsah RM, Netticadan T (2000). Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18: 655-673.
11. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR (1997). Somatic Mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. U.S.A. 94: 10895-10900.
12. Jančinová V, Drábiková K, Nosál R, Holomáňová D (2006). Extraand intracellular formation of reactive oxygen species by human neutrophils in the presence of pheniramine, chlorpheniramine and brompheniramine. Neuroendocrinol. Lett. 27:141-143.
13. Jenner P (2003). Oxidative stress in Parkinson's disease. Ann. Neurol. 53:S26-S36.
14. Kato K, Nitta H, Mizuno H (1973). Infrared spectroscopy of some mannans. Agric.Biol.Chem. 37:433-435.
15. Kogan G, Pavliak V, Masler L (1988). Structural studies of mannans from the cell walls of the pathogenic yeasts Candida albicans serotypes A and B Candida parapsilosis. Carbohydr. Res. 172: 243-253.
16. Kogan G, Šandula J, Šimkovičová V (1993). Glucomannan from Candida utilis. Folia Microbiol. 38:219-224.
17. Kougias P, Wei D, Rice PJ, Ensley HE, Kalbfleisch J, Williams DL, et al., (2001). Normal human fibroblasts express pattern recognition receptors for fungal (1→3)-β-D-glucans Infect. Immun. 69: 3933-3938.
18. Levine RL, Williams J, Stadtman ER, Shacter E (1994). Carbonyl assays for determination of oxidatively modified proteins. Meth. Enzymol. 233: 346-357.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275.
20. Miadoková E, Svidová S, Vlǩová V, et al., (2006). Diverse biomodulatory effects of glucomannnan from Candida utilis. Toxicol. In Vitro 20:649-657.
21. Nosĺ R, Jančinová V, Petríková M, Poništ S, Bauerová K (2007). Suppression of oxidative burst of neutrophils with methotrexate in rat adjuvant arthritis. Chem. Listy 101: 243-244.
22. Ondrejičková O, Ziegelhoeffer A, Gabauer I, Sotniková R, Styk J, Gibala P, et al., (1993). Evaluation of ischemia-reperfusion injury by malondialdehyde, glutathione and gamma-glutamyl transpeptidase: Lack of specific local effects in diverse parts of the dog heart following acute coronary occlusion. Cardioscience 4: 225-230.
23. Orlowski M, Meister A (1970). The gamma-glutamyl cycle: A possible transport system for amino acids. Proc Natl Acad Sci USA. 67:1248-1255.
24. Rice-Evans C, Miller NJ (1994). Total antioxiclant status in plasma and body fluids. Meth. Enzymol. 234: 279-293.
25. Sayre LM, Smith MA, Perry G (2001). Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8: 721-738.
26. Schepetkin IA, Quinn MT (2006). Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 6: 317-333.
27. Tzianabos AO (2000). Polysaccharicle immunomodulators as therapeutic agents: structural aspects and biological function. Clin. Microbiol. Rev. 13: 523-533.
28. Valko M, Leibfritz D, Moncol J, Cronin NIT, Mazur M, Telser J (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39:44-84.
29. Vlčková V, Dúhová V, Svidová S, Farkašová A, Kamasová S, Vlček D, et al (2004). Antigenotoxic potential of glucomannan on four model test systems. Cell Biol.Toxicol. 20: 325-332.